Drug Use Utilization Of Antibiotics In Covid-19 Patients At Ajibarang Regional General Hospital

Andra Nurjaya Maulana^*, Heny Ekowati, Nialiana Endah Endriastuti

Pharmacy Department, Faculty of Health Sciences, Universitas Jenderal Soedirman,

Jl. Dr. Suparno, Karangwangkal, Purwokerto 53123, Indonesia

*Corresponding author : Phone. 082214165100, e-mail : andra.maulana@mhs.unsoed.ac.id

Co-author 1. e-mail : heny.ekowati@unsoed.ac.id

Co-author 2, e-mail : nialiana.endriastuti@unsoed.ac.id

ABSTRACT

Introduction: Coronavirus Disease 2019 (COVID-19) is a disease caused by SARS-CoV-2. One of the most widely used treatments for COVID-19 patients is antibiotics. This study aimed to describe the use of antibiotics inpatient diagnosed with COVID-19 at the Ajibarang Regional General Hospital, Banyumas Regency.

Methods: This study used a descriptive observational design method. Data collection was carried out retrospectively and obtained from patient medical record data from March 2020 to December 2020. The subjects in this study were inpatient diagnosed with COVID-19 at the Ajibarang Regional General Hospital, Banyumas Regency who received antibiotic therapy from March 2020 to December 2020.

Results: The results showed as many as 5 patients (2.84%) received Ampicillin, 6 patients (3.41%) received Gentamicin, 37 patients (21.03%) received Ceftriaxone, 4 patients (2.27%) received Cefotaxime, 34 patients (19.31%) received Levofloxacin, 6 patients (3.41%) received Cefixime, 75 patients (42.61%) received Azithromycin, 4 patients (2.27%) received Cefadroxil, 1 patient (0.57%) received Doxycycline, 1 patient (0.57%) received Clindamycin, 1 patient (0.57%) received Isoniazid, 1 patient (0.57%) received Meropenem, and 1 patient (0.57%) received Amoxicillin.

Conclusion: The results showed that the most widely used antibiotic therapy at Ajibarang Regional General Hospital was Azithromycin with a percentage of 42.61%.

Keywords: COVID-19; Antibiotics; Ajibarang Hospital